Accession Number:

AD1041711

Title:

Pyridostimine Bromide 30mg Stability in Extended Storage Conditions

Descriptive Note:

Conference Paper

Corporate Author:

59th Medical Wing San Antonio United States

Personal Author(s):

Report Date:

2017-12-03

Pagination or Media Count:

3.0

Abstract:

Pyridostigmine bromide 30mg is approved by the Federal Drug Administration FDA as a pre-treatment of nerve gas exposure. The package insert specifiespyridostigmine needs to be refrigerated while stored and discarded three months after removal from the fridge and dispensing. The objective of this study is to determine the stability of pyridostigmine under extended storage conditions.

Subject Categories:

  • Pharmacology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE